A missense mutation in the BRCA2 gene in three siblings with ovarian cancer
1998

BRCA2 Gene Mutation in Sisters with Ovarian Cancer

Sample size: 3 publication Evidence: moderate

Author Information

Author(s): S Roth, P Kristol, A Auranen, M Shayeghi, S Seal, N Collins, R Barfoot, N Rahman, P J Klemi, S Gr6nman, L Sarantaus, H Nevanlinna, R ButZow, A Ashworth, MR Stratton, LA Aaltonen

Primary Institution: Haartman Institute, Department of Medical Genetics, University of Helsinki

Hypothesis

Is there a specific mutation in the BRCA2 gene that contributes to ovarian cancer in a Finnish family with three affected sisters?

Conclusion

The study identified a missense mutation in the BRCA2 gene that is likely associated with ovarian cancer in the three sisters.

Supporting Evidence

  • The mutation was not found in 220 cancer-free Finnish controls.
  • The mutation was present in all three sisters with ovarian cancer.
  • Loss of heterozygosity was observed in one tumor sample from the sisters.

Takeaway

Three sisters in a family had ovarian cancer because of a change in a gene called BRCA2, which helps protect against cancer.

Methodology

The entire coding sequence of the BRCA2 gene was screened using conformation-sensitive gel electrophoresis and direct sequencing.

Limitations

The mutation's functional significance has not been evaluated, and the variant was not found in a large series of controls.

Participant Demographics

Three sisters from a Finnish family with a history of ovarian cancer.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication